COMMUNIQUÉS West-GlobeNewswire
-
TeamACO reduces avoidable costs by $15.8M for Medicare value-based care program
03/09/2025 -
Instinct Science & VECCS Partner to Bring Essential Reference Plumb’s Veterinary Drugs and Standards of Care to Emergency & Critical Care Teams
03/09/2025 -
Carbon Capture Made Scalable: Decarbontek Debuts Breakthrough Modular Adsorbent Technology
03/09/2025 -
MATTER Launches Major Initiative to Improve Health System in Ukraine
03/09/2025 -
BVI Unveils Virtuoso® – A Novel Dual-Function Surgical Platform for Cataract and Vitreoretinal Procedures
03/09/2025 -
10 Surgeons Join USOSM Partner Practices in Eight States
03/09/2025 -
Ernexa Therapeutics Announces Presentation At The H.C. Wainwright 27th Annual Global Investment Conference
03/09/2025 -
PharmAla Incorporates Australian Entity for Clinical Research
03/09/2025 -
Dogwood Therapeutics to Participate in Fireside Chat at the H.C. Wainwright 27th Annual Global Investment Conference
03/09/2025 -
Adagene Appoints Immuno-Oncology Pioneer, Axel Hoos, M.D., Ph.D., as Executive Advisor
03/09/2025 -
PacBio and EpiCypher Partner to Deliver Novel Insights into Epigenomics with Fiber-seq Workflow
03/09/2025 -
Persephoni Launches Strategic Sponsorship with American Cancer Society’s BrightEdge to Accelerate Oncology Innovation
03/09/2025 -
Northwest Kidney Centers and Outset Medical Announce Collaboration to Grow Home Hemodialysis
03/09/2025 -
Limited Healthcare Access Leaves Families Paying the Price
03/09/2025 -
GRI Bio to Present at the H.C. Wainwright 27th Annual Global Investment Conference
03/09/2025 -
Artelo Biosciences Announces Positive Interim Phase 2 CAReS Results for the Treatment of Cancer Anorexia-Cachexia Syndrome (CACS)
03/09/2025 -
Outlook Therapeutics to Present at the 2025 EURETINA Innovation Spotlight (EIS)
03/09/2025 -
Journey Medical Corporation to Participate in September 2025 Investor Conferences
03/09/2025 -
PolyPid to Participate in the Upcoming 27th Annual H.C. Wainwright Global Investment Conference
03/09/2025
Pages